Publication | Closed Access

Baseline Very Low-Density Lipoprotein Cholesterol is Associated with the Magnitude of Triglyceride Lowering on Statins, Fenofibric Acid, or Their Combination in Patients with Mixed Dyslipidemia

Metabolic SyndromeCardiovascular DiseaseHealth PolicyMixed DyslipidemiaHyperlipidemiaDyslipidemiaFenofibric AcidLipoprotein MetabolismPublic HealthAtherosclerosisEpidemiology